Modavar Pharmaceuticals
Modavar Pharmaceuticals LLC is a wholly-owned subsidiary of Cadila Pharmaceuticals, Ltd., Ahmedabad, India and aims to emerge as a formulation sales and marketing arm of Cadila Pharmaceuticals into North America. Modavar, in conjunction with Cadila Pharmaceuticals, India is committed to supply affordable, quality formulations using some of the most aggressive research methods and cutting edge manufacturing processes.
Last updated on
About Modavar Pharmaceuticals
Founded
2005Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$150KCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
Washington, D.C.State
District of ColumbiaCountry
United StatesModavar Pharmaceuticals
Find your buyer within Modavar Pharmaceuticals